Continuous Peripheral Nerve Block Catheter Market to Reach US$ 742.7 Billion, Globally, by 2027 at 6.1% CAGR: FMI

Future Market Insights has delivered key insights and presented a revised forecast analysis on continuous peripheral nerve block catheters market in its new research study titled “Continuous Peripheral Nerve Block Catheter Market: Global Industry Analysis (2012-2016) and Forecast (2017-2027)”. Continuous peripheral nerve block catheter are increasingly being used for pain management in patients undergoing upper/lower extremity surgeries and patients suffering from trauma, owing to their advantages, such as meticulous precision and low-price. Continuous peripheral nerve block catheter are emerging as a credible alternative to opioids for pain management as ill-effects associated with opioids are very severe such as addiction to opioids

Global Continuous Peripheral Nerve Block Catheter Market: Forecast Highlights

The global continuous peripheral nerve block catheter market is anticipated to record a CAGR of 6.1% and the market is estimated to reach a value of US$ 742.7 Mn in 2027 from a valuation of around US$ 411 Mn in 2017.

To remain ‘ahead’ of your competitors, request for a sample

Global Continuous Peripheral Nerve Block Catheter Market: Segmental Analysis

The market is segmented based on product type, insertion technique, indication, end users and regions. On the basis of product type, the market has been segmented into stimulating catheter system, non-stimulating catheter systems and over-the-needle catheter systems. Non-stimulating catheter systems segment dominated the global continuous peripheral nerve block catheter market in terms of value and volume in 2017. This segment is expected to continue its dominating streak throughout the forecast period.

On the basis of insertion technique, the continuous peripheral nerve block catheter market has been segmented into nerve stimulation and ultrasound based insertion technique. Continuous peripheral nerve block catheter that uses ultrasound based insertion technique is expected to witness higher demand than devices that use nerve stimulation technique for catheter insertion. The ultrasound based insertion technique segment is projected to grow at a higher rate during the forecast period. However, the nerve stimulation based insertion technique segment is expected to show a higher market valuation.

On the basis of indication, the continuous peripheral nerve block catheter market has been segmented into trauma cases, upper extremity surgeries, lower extremity surgeries, pain management and other indications. Amongst these aforementioned segments, lower extremity surgeries segment is expected to witness higher revenue growth as compared to other segments over the forecast period and this segment is expected to show higher value CAGR throughout the period of assessment.

Key end-use sectors that generate the bulk of demand for continuous peripheral nerve block catheter can be broadly categorised into hospitals and ambulatory surgical centres. Among these, hospitals account for the largest revenue share of the market, owing to increasing number of hospitalisations for upper/lower extremity procedures carried out in hospitals. The hospital segment is a highly lucrative segment from an investment standpoint.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1307

FMI’s report has segmented the global continuous peripheral nerve block catheter market on the basis of region into North America, Western Europe, Eastern Europe, Latin America, Asia Pacific Excluding Japan (APEJ), Middle East & Africa and Japan. This report assesses trends driving each market segment and offers analysis and insights about the potential of continuous peripheral nerve block catheter in specific regions. The North America region is the leading region in terms of global revenue share, followed by Western Europe and Japan. North America is estimated to dominate the continuous peripheral nerve block catheter market with maximum value share of the overall market by end of 2017. North America continuous peripheral nerve block catheter market increase at a CAGR of 6.5% through 2027. Presence of key regional players, strong distribution network, and developed healthcare infrastructure are the key factors driving the growth of the market in North America.

Global Continuous Peripheral Nerve Block Catheter Market: Competitive Assessment

Some key players in the global continuous peripheral nerve block catheter market identified include:

B. Braun Melsungen AG,

Teleflex Incorporated,

Halyard Health, Inc.,

Epimed International Inc.

Pajunk GmbH.

Market Segmentation

By Product Type

Stimulating Catheter

Open Tip Catheter Stimulating Catheter

Closed Tip Catheter Stimulating Catheter

Non-Stimulating Catheter

Open Tip Catheter Non-Stimulating Catheter

Closed Tip Catheter Non-Stimulating Catheter

Over-The-Needle Catheter

By Insertion Technique

Nerve Stimulation Based Insertion

Ultrasound Based Insertion

By Indication

Trauma Cases

Upper Extremity Surgeries

Lower extremity Surgeries

Pain Management

Other Indications

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1307

By End User

Hospitals

Ambulatory Surgical Centers

By Region

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific Excluding Japan

Japan

Middle East & Africa

Systemic Infection Treatment Market Research Report: Key Drivers and Restraints, Opportunities, Industry Share & Trend Analysis Report to 2027

Systemic Infection are the type of pathogenic infection that spreads throughout the body. It can be comprised of bacterial, viral or fungal infections. The main characteristic of systemic infection is affecting the bloodstream of a person and thus spread to the whole body. The systemic infections can vary from the common ones such as cold, flu, strep throat or can be life-threatening like STDs. Conventional methods used for the diagnosis of these type of infections might delay the therapy process. Nowadays, modern day techniques such as ELISA and PCR are most used for more specific and quick results.  Treatment depends upon the type and severity of infection. Generally, antibacterial, antiviral and antifungal drugs are given for the treatment by either oral or intravenous mode of administration. Oral route of administration is the safest, economical and the easiest way of treatment. Nowadays, multi drug resistance is one of the growing concern for the treatment of pathogens. The treatment becomes difficult in some cases as infection spreads throughout the body.

By the increased number of people with reduced immune response has led to increased prevalence of systemic infections. On the other hand, a large number of anti-infectives are available in the market which thus increase the overall market of systemic infection treatment.

Systemic Infection Treatment Market: Drivers & Restraints

Systemic Infection Treatment market is likely to proliferate in the future as per existing trends for the increase in the patient pool across the globe. Large number of research studies these days has increased the number of treatment options with more efficient results which thus drives the growth of systemic infection treatment market. Funding and assistance programs by the government as well as non-government agencies are also aiding in the overall market increase. Microbial resistance to various anti-infectives is one of the limiting factor that curbs the market growth. Non-availability of drugs for deadly systemic infections such as HIV or the huge cost of treatment is also a hurdle for the market growth. Increase in number of key players in the market increases the competition which restricts new players to enter the market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3423

Systemic Infection Treatment Market: Overview

With the ever increasing number of pharmaceutical industries and large number of products in the market intensifies the competition. Innovative and cost effective products would be the cutting edge to become a key player in the market. Generic competition is more in the market comprising 60% of the total sales. Novel biologics with improved drug delivery and target specific approach are the demand for the growing systemic infection treatment market. By maintaining the safety and efficacy of the drug will always pushes the companies towards growth. Many global key players have a large number of drugs for the systemic infection treatment in the pipeline which thus help in driving the market.

Systemic Infection Treatment Market: Region-wise Outlook

North America and European regions have the established market with large number of global key players in their market. This is due to the favorable health facilities and healthy reimbursement scenario in these developed nations. Furthermore, growth availability is seen in the countries of Asia-Pacific, Middle East and Africa, which has a large pool of patients with systemic infections. A huge number of pharmaceutical industry base is seen in growing economies like India and China with higher growth rate, thus increasing the opportunity for investment in these countries. Increasing awareness, health facilities and government efforts are the driving factors for the systemic infection treatment market growth in these countries.

Systemic Infection Treatment Market: Key Players

Some of the global key players manufacturing branded as well as generic therapeutic in Systemic Infection Treatment market include

  • Abbott Laboratories,
  • Merck & Co., Inc.,
  • Pfizer, Inc.,
  • GlaxoSmithKline plc,
  • Novartis AG,
  • Johnson & Johnson,
  • Sun Pharmaceuticals,
  • Roche,
  • Astra Zeneca plc,
  • Wockhardt ltd,
  • Mylan Pharmaceuticals Inc

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3423

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Systemic Infection Treatment Market: Segmentation

Segmentation by Treatment Type

  • Antibacterial
  • Antiviral
  • Antifungal

Segmentation by Mode of Administration

  • Oral
  • Intravenous
  • Topical

Segmentation by Drug Availability

  • Generic
  • Branded

Segmentation by Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3423

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

PARP Inhibitors Market Is Estimated To Be Valued At US$ 8.4 Billion By 2021 And Forecast To 2026

Rising burden of various types of cancers such as ovarian, breast, prostate, and pancreatic cancer is anticipated to generate significant demand for PARP inhibitors. According to the Global Cancer Observatory (GLOBOCAN), countries such as China, the U.S., India, and Japan, collectively diagnose over 120,000 new cases of ovarian cancer each year. The incidence of breast cancer is much higher in these countries, and with superior efficacy of PARP inhibitors as compared to other available cancer treatment options, the PARP inhibitors market is expected to gain significant revenue over the forecast period.

The global PARP inhibitors market is estimated to be valued at US$ 8.4 Bn by 2026, expanding at a significant CAGR from 2019 to 2026.

“The unique ability of PARP inhibitors to improve progression-free survival in ovarian and breast cancer patients is expected to generate extensive traction for the market, thereby propelling the growth of the global PARP inhibitors market over the forecast period.”

Key Takeaways of PARP Inhibitors Market Study

Olaparib, with various expanded approvals for the treatment of ovarian cancer, breast cancer, and pancreatic cancer, and rapid increase in potential patient pool, contributed to the dominance of the segment by drug in 2018, and will continue to do so during the forecast period.

PARP inhibitors are regarded as a new standard of care for ovarian cancer after first-line platinum chemotherapy. Adoption of PARP inhibitors for ovarian cancer treatment has surged, and the trend is expected to continue during the forecast period, owing to the ability of PARP inhibitors to induce ovarian cancer patients into remission for longer periods of time as compared to any other marketed therapy.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-3197

With a strong pipeline, significant number of PARP inhibitors are expected to go for approval through the new drug application (NDA) process and for expanded approval to treat various types of cancers.

 

Strategic Acquisitions & Collaborations by Key Players to Widen Regional Presence

All marketed PARP inhibitors are under patent, and with no generic launch in sight till 2027, the market is expected to remain consolidated till the second half of this decade. Key players in the PARP inhibitors market are undergoing major collaborative efforts, mergers, and acquisitions in order to expand their regional product offerings. For example, in January 2019, GlaxoSmithKline plc acquired TESARO Inc., an oncology-focused biopharmaceutical company with a marketed PARP inhibitor named Zejula (Niraparib).

More Valuable Insights on PARP Inhibitors Market

Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2015 to 2026. The global PARP inhibitors market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on PARP inhibitors market on basis of drug (Olaparib, Niraparib, Rucaparib, and Talazoparib), indication (ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer), and distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies), across seven major regions.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3197

PARP INHIBITORS MARKET TAXONOMY

The global PARP inhibitors market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Drug

  • Olaparib
  • Niraparib
  • Rucaparib
  • Talazoparib

Indication

  • Ovarian Cancer
  • Breast Cancer
  • Prostate Cancer
  • Pancreatic Cancer

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3197

Region

North America

Europe

Latin America

South Asia

East Asia

Oceania

Middle East And Africa

Clinical Trials Market Trends, Key Driven Factors, Region-wise Outlook, Segmentation And Forecast To 2021-2029

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018. The healthcare sector is closing in on a new era of clinical trials, which are more engaged with patients, streamlined and connected. With development costs reaching record highs and patents approaching cliffs, companies are strengthening their R&D efforts to keep pace with change. Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases.

“The ubiquity digital technologies is evidently growing, as these (including but not limited to ingestible devices, sensors, and wearable health monitors) hold the potential to disrupt the aspects of clinical trials. Digital technologies are revolutionizing the antiquated process of new drug development, even as optimizing the way health data is collected, measured, and assessed”.

According to the study, the clinical trials landscape is witnessing a paradigm shift toward patient centricity, in a bid to incorporate perspective of patients during the clinical trial design. Clinical trial sponsors have aligned their methods with the voice of patients, by launching communication channels during the study’s execution. Key enterprises are adopting unconventional approaches by implementing site-centric method, using operational support systems and technology for bringing studies to the trial-naïve physicians.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-384

Industry Sponsors Account for Majority Clinical Trial Spending

The most remarkable advances in medicine are realized from sponsorships of companies for clinical trials, in the anticipation of turning a profit. A notable percentage of clinical trials being conducted to support approval of vaccines, devices, or drugs, and track their safety, have been industry-sponsored in recent years.

The study estimates industry-sponsored clinical trials to account for ~60% of overall spending in 2019, and in the foreseeable future. Recent studies state that industry-sponsored trials yield positive results compared to academic-run trials, which also account for a significant share of clinical trial spending.

According to FMI, sponsors, such as academic institutes, research institutes and medical centers, are estimated to account for ~30% clinical trial spending in 2019. As the imperativeness of evidence-based therapies continue to be progressively emphasized, most of the randomized clinical trials are driven by the ability of developing profitable new therapies. Guidelines recommended by regulatory bodies for clinical trial enrichment, and risk-based monitoring are likely to lay the groundwork for more targeted approach toward cost-intensive clinical trials.

The study opines that North America and Europe will continue to lead the clinical trials landscape, collectively accounting for ~80% of global spending. These regions present a standardized and favorable environment for the clinical trials landscape, in light of their economic vigor that enables them to benefit from most of the technology disruptions prior to other nations. Pharmaceutical and medical device giants in these two regions are adopting AI for disrupting every stage of the clinical trial, which range from linking studies to eligible patients, to data collection and adherence.

According to the study, opportunities abound for conducting clinical trials in developing economies, such as in East Asia and South Asia, owing to the access to huge patient pool. Sponsors are likely to realize greater success in these regions as low government healthcare budgets represent cost-effective methods of providing patients with access to innovative therapies. Additionally, conducting clinical trials in these regions comes with other broader advantages, including pragmatic & efficient regulatory pathway, and tax incentives for conducting the trials.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-384

Key Segment

By Area

  • Oncology
  • Infectious Disease
  • Metabolic Disorders
  • Cardiovascular
  • Neuroscience
  • Respiratory
  • Others

By Phase

  • Phase 0
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Sponsor

  • Industry-sponsored
  • Government / Public
  • Non-governmental Organizations
  • Others (Academic Medical Centers, Individuals, etc.)

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-384

Molecular Diagnostics Market 2021 End-User Demand by Types, Regions,Top Players, Service Provides, Regional Outlook and Forecast to 2026

Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved. Molecular Diagnostics helps to decide the therapies are suitable for individual patients. The new advanced technologies has qualified the instruments in providing accurate results. This ability of the diagnostic tool resulted in increased rate of acceptance of the molecular diagnostics. The concept of personalized medicine has emerged out of molecular diagnostics.

Molecular Diagnostics Market: Drivers & Restraints

The factors driving molecular diagnostic market are increase in demand for care facilities, favorable regulatory policies which aims at promoting the care diagnosis, acceptance of personalized medicine, development in biomarkers, advancements in proteomics, increasing awareness of the diagnostic procedures. However rising cost of molecular diagnostics, obligation of skilled labors to handle the complexity of instruments are the factors restraining the growth of molecular diagnostics market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1262

Molecular Diagnostics Market: Overview

The awareness of diagnosis is giving rise to the trend of self-care management. The early diagnosis of disease or disorder helps the patient in getting better treatment and cure. Infectious disease and Oncology is estimated to be the fastest growing application owing to the increased prevalence of cancer and demand for early diagnosis. The introduction to specific biomarkers for the treatment has a positive impact over the molecular diagnosis market. However maximum use of reagents is estimated owing to their accurate results. Commonly used reagents are salts, formamide, sodium dodecyl sulfate and dextran sulphate heparin. Growing awareness about the prenatal genetic testing for early detection of chromosomal abnormalities during pregnancy has enhanced the use of molecular diagnostics.

Molecular Diagnostics Market: Region-wise Outlook

Depending on geographic regions, the Global Molecular Diagnostics market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. North America is estimated to be the largest player in molecular diagnostic market owing to the technological advancements and innovations, increase in R&D investments by large pharmaceutical and biotechnological industries and demand for early diagnosis. Asia Pacific is estimated in rising molecular diagnostic market due to increase in the prevalence of diseases such as cardiovascular diseases, infectious diseases and large population suffering from diabetes.

Molecular diagnostics Market: Key Players

Some of the key players identified in the molecular diagnostic market are Abbott laboratories, Becton Dickinson, Novartis, Roche Diagnostics, Johnson and Johnson, Bio-Rad Laboratories, bioMerieux, Danaher Corporation, Qiagen N.V, Siemens Healthcare, Cepheid, Hologic, Inc,.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1262

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest Of Latin America)
  • Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Molecular Diagnostics Market: Segmentation

Molecular diagnostic market is classified on the basis of product, technology, application, end use and geography.

Based on product, the global molecular diagnostic market is segmented into the following:

  • Instruments
  • Reagents
  • Others (service and software)

Based on technology, the global molecular diagnostic market is segmented into the following:

  • DNA sequencing
  • Polymerase chain reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Transcription Mediated Amplification (TMA)
  • In situ hybridization
  • Sequencing
  • Microarrays
  • Mass spectrometry
  • DNA sequencing
  • Others (southern blotting, northern blotting, electrophoresis)

Based on application, the global molecular diagnostic market is segmented into following:

  • Cancer
  • Pharmacogenomics
  • Genetic testing
  • Infectious disease
  • Prenatal
  • Neurological disease
  • Cardiovascular disease

Based on end use, the global molecular diagnostic market is segmented into following:

  • Diagnostic laboratories
  • Hospitals
  • Others( nursing home, blood banks, point of care)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1262

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Bariatric Patient Room Market Key Players – Hill-Rom, Nemschoff, Brayton, NewCare, Stryker Medical, Softcare

There is a significant increase in the number of bariatric admissions to healthcare facilities in the United States. This has led to a challenging time for healthcare providers and facilities that are trying hard to provide much needed care to bariatric patients that is effective, dignified and safe for both the patient and the care provider. Hence, while designing new hospitals and retrofitting the existing ones, care is taken to ensure that bariatric patients are accommodated. The facilities that the bariatric patient room market offers are designated bariatric rooms with adjoining bariatric toilet rooms, non-corridor doors, operating tables with 600 pounds weight limits, CT scanners with a bariatric tables and special 600 and 1000 pounds patient lifts in the ICU.

While there are no specific guidelines for designing bariatric patient rooms, some best practices have been conceptualized by the architects and designers to ensure that bariatric patients are comfortable in their stay in a healthcare facility. Owing to the obesity epidemic in the United States, the average size patient for whom hospitals should be designing now weighs 330 pounds. However, while designing healthcare facilities for bariatric patients, this measurement increases to 1000 pounds. So with the awareness about Bariatric patient room design increasing, there is a lot of scope for a boom in the bariatric patient room market.

Bariatric Patient Room Market: Drivers

Hospitals all across the United States are struggling to serve an increasing number of obese patients, and are adopting new design guidelines to accommodate such kind of patients. This has led to a sharp focus on bariatric patient room market that is poised to show a robust growth. In addition, going through a bariatric surgery has become relatively necessary for people who are obese and overweight. Due to the increasing prevalence of obesity in developed western countries, the awareness about bariatric surgery has increased. This has generated a need for conducive environment for bariatric patients in the healthcare facilities where there every need is met easily and they are comfortable during their surgery and recovery phase.

In order to treat bariatric patients, healthcare providers must invest in equipment, furniture and renovation that support heavier patients. The median estimated cost of obesity related renovations is $100,000. However, such costs are being recovered by the hospitals through the increase in popularity of bariatric surgeries, and Medicare reimbursements. Also, equipment inventory cost is recovered within 6 months. All this contributes to the growing bariatric patient room market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2142

Bariatric Patient Room Market: Restraints

While most healthcare facilities recognize the need to modify existing spaces and create better spaces to support an increasing bariatric patient population, there is no specific minimum weight requirement or code to follow. What complicates the matter further is the fact that there is a complete lack of a standard for what defines a bariatric patient. In addition, rates of obesity vary from region to region, making it difficult to cater to requirements that would be applicable universally. Apart from this, it should be noted that caring for obese and overweight patients cost an average of 37% more than treatment of non-obese patients.

Bariatric Patient Room Market: Key Regions

As per the available data, the North America bariatric surgery market was the largest in 2014, with increasing amount of investment by both the government and the industry to counter the ill effects caused by obesity. Also, the initiatives by the United States government in the healthcare sector makes the North American bariatric patient room market lucrative. Obesity is also increasing at an alarming rate in Europe, making it a growing market for bariatric patient rooms. Asia Pacific is the fastest growing market for bariatric surgery and hence the market for bariatric patient rooms is also gaining huge traction.

Bariatric Patient Room Market: Key Market Players

The bariatric patient room market is growing fast, however it is not dominated by one key player in particular. Some of the important companies in the field of bariatric market in the United States are Hill-Rom, Nemschoff, Brayton, NewCare, Stryker Medical, Softcare and a few others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2142

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2142

Bariatric Patient Room Market

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Immunochemistry Analyzer Market Impacted by COVID-19, Market to Remain Dormant in Near Term, Projects FMI 2021-2025

Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots.

There are approximately more than 180,000 immunochemistry analyzers were installed globally in 2013. Out of which only about 17-20% of these analyzers are installed in the United States. This statistic suggests that the markets like China, India, and Japan where there is lack of basic lab facility prevails are adopting this new technology .Also it’s been seen that the recurring consumable sales are a strong factor to segment growth.

Immunochemistry analyzers are instruments that automatically run tests on samples from patients to detect any number of biologically active substances .It is very important to know which analyzer to use as different analyzers have different analysis time, and need different reagents which make these instrument highly sophisticated. These analyzers are mainly being used in infectious disease testing, cancer, cardiac, and autoimmune diseases.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-866

Immunochemistry Analyzer Market: Drivers and Restraints

Under the strong rules & regulation laboratories find it difficult to have good revenues. Thus it’s very important to find ways to sustain in such a cost-crunched environment. Due to the cost cutting in clinical lab fees, profitability per test is decreasing which makes it necessary for the laboratories to focus on the volume rather than the value. There is also heavy pressure for quality, error-free results to ensure patient satisfaction. This forces labs to lean toward more automated systems with effective workflow solutions.

In US, Laboratories are encouraged for automation due to the heavy influx of patients with insurance coverage. But with limited workforce in the clinical lab it’s difficult to manage the huge inflow of patients. On the other hand patients need prompt & error free results. Thus this scenario demands laboratories to seek the help of systems that have a high accuracy, with managing high growing volumes and also offer remote data acquisition capabilities. The automated analyzers working with barcode readers, rack detection systems, and sample/plate identification modules to avoid plate or sample switch.

Immunochemistry Analyzer Market : Overview

With the rapid technological advancement in healthcare industry the immunochemistry analyzer market is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Globally, the immunochemistry market represents approximately 40.1% of the global in vitro diagnostics (IVD) market. Immunochemistry is by far the largest segment by volume, mostly due to routine testing. It is primarily driven by growing access to healthcare.

Immunochemistry Analyzer Market : Region-wise Outlook

Depending on geographic region, global immunochemistry analyzer market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Demand for immunochemistry analyzers is slowing in the US and Western and Eastern Europe. Europe’s challenges in this segment include laboratory consolidation in France and economically troubled Greece, Italy, Spain, and Portugal. China’s growing rural hospital market lacks basic diagnostics laboratory infrastructure and represents an untapped opportunity for affordable immunochemistry analyzers.

Immunochemistry Analyzer Market : Key Players

The market is fully fragmented with leading brands, such as Siemens, Abbott Diagnostics, Beckman Coulter, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc.  and F. Hoffmann-La Roche Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-866

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Immunochemistry Analyzer Market:Segmentation

Immunochemistry analyzer market is segmented into following types:

Instruments

Reagents

Global immunochemistry analyzer Market, by Instrument Type

Instruments

Immunochemistry Analyzers

Chemiluminescence Immunoassay (CLIA) Analyzers

Immuno Fluorescence (IFA) Analyzers

Enzyme Immunoassay (EIA) Analyzers

Radioimmunoassay (RIA) Analyzers

Enzyme Linked Fluorescent Assay (ELFA) Systems

Multiplexed Assay Systems

Immunochemistry Stainers

Automated Stainers

Semi-Automated Stainers

Global Immunochemistry analyzer Market, By Application

Endocrinology

Oncology

Cardiology

Therapeutic Drug Development & Monitoring

Infectious Disease Testing

Drugs Of Abuse Testing

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-866

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Vibrating Screen Market Is Projected To Total US$ 2.3 Bn By 2028

Sales in the global vibrating screen market are slated to top US$ 1.37 Bn in 2022. Expanding at a healthy 7.6% CAGR, the market size is projected to total US$ 2.3 Bn by 2028. Future Market Insights (FMI), in its latest research, evaluates the vibrating screen market which includes global industry analysis 2014–2018 and opportunity assessment 2019–2029. The report investigates the vibrating screen market and provides critical insights for the forecast period of 2019-2029. As per the research, the global vibrating screen market was valued at ~ US$ 1 Bn in 2018, and is estimated to increase at a CAGR of ~7% between the forecast period of 2019 and 2029.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1789

Upswing in mining processes to suffice the requirement for precious metals and hard rock minerals as well as in construction activities to build infrastructure assets is the messiah of pain points of the global vibrating screen market, suggests FMI. On the contrary, the growth trail will get hindered by tumbling mining operations on grounds of environmental amendments to curb carbon footprint and high attrition rate among miners due to on-site adversaries.

Vibrating screens have been hitting the mark with innovations over the years as sieving equipment in grading and screening of the required material, which would have been otherwise impossible. FMI’s study suggests that major market players are including add-ons to the existing and new equipment for better screening efficacy and elongated life-cycle.

Demand for Circular Vibrating Screens in Mining Industry to See an Upturn

Circular vibrating screens are inundating more than half of the market revenues, as per FMI’s study. The mining industry, including coal mines, and quarrying sites, is leveraging circular vibrating screens owing to their ability to classify materials with large specific gravity, large particles and great rigidity. The exciter of circular vibrating screens is mounted above the center of gravity of the screen box and the upper tip of elliptical long axis of the feeding end is positioned towards the leakage direction, which results in higher processing capacity per unit time than that of its linear counterpart.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-1789

On the flip side, the complexity of shakers and fast-rate rotation of the two shafts in linear vibrating screens imply high fueling demands. Further, the FMI’s study finds that linear vibrating screens are chiefly utilized for classification of fine particles, light weight, and low stiffness materials, making them suitable for industries such as, building materials, chemical, and pharmaceutical.

By Segmentation:

Product Type:

  • Linear Vibrating Screens
  • Circular Vibrating Screens
  • Elliptical Vibrating Screens

Drive Type:

  • Direct Drive
  • Indirect Drive

End-use Industry:

  • Construction
  • Mining
  • Recycling
  • Others (Iron & Steel, Power, etc.)

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-1789

Manufacturers showing Stauncher Inclination toward Direct Drive System

As per the FMI’ report, adoption of direct drive system in vibrating screen accounts for more than 50% of the market revenues owing to the absence of gearboxes and belts in the design, which results in lesser wear and tear between the components. The direct drive system is cost-efficient as the moving parts in the operation and framework are less complicated. For noise abatement, the direct drive system comes up with simple arrangement and lesser moving components which may vibrate during mechanism. Furthermore, the reduced number of kinetic parts prevent easy loss of energy due to friction, enabling better efficacy, improved accuracy and increased life-cycle of the vibrating screen components. The indirect drive system, on the other hand, is subjected to friction between constituents including, gears, couplers, and pulleys, implying decreased efficiency and precision.

Surgical Navigation System Market Key Players – GE Healthcare Ltd., Medtronic Inc., Siemens Healthcare Corporation, Stryker Corporation, B.Braun Melsungen AG, Bausch & Lomb Incorporated

Surgical Navigation Systems is one of the most reliable technology which is developed to render surgeries safer and less invasive as compared to the surgeries without Surgical Navigation Systems. Navigation during surgery is an excellent technology applied currently in medical devices. Surgical Navigation Systems have accelerated the technical processes in a surgery and paved the way for complex procedures. Surgical Navigation Systems target the anatomy to be operated on and guide to place the implant safely to the particular anatomy of the human body. Surgical Navigation Systems act as information centers during surgeries. Surgical Navigation System is essential in accurate visualization of the anatomy and in surgery planning in a virtual environment. Surgical Navigation Systems reduce risks associated with surgeries.

Surgical Navigation System Market: Drivers & Restraints

The global surgical navigation system market is driven by the navigation technology which encompasses surgical planning software, intra-operative imaging and instrument tracking technologies. Surgical Navigation Systems aid in guiding the surgeons to make data-oriented decisions during surgeries. This Surgical Navigation System technology is a driver for the global Surgical Navigation Systems market. A major factor that could adversely affect the growth of the global Surgical Navigation Systems market is the surge of minimally invasive and non-invasive surgeries. The minimally invasive and non-invasive surgeries are becoming popular among the masses owing to the rapid post-operative recovery with minimal pain to the patient.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-977

Surgical Navigation System Market: Overview

Surgical Navigation System is also known as computer-aided surgery or computer-assisted intervention. The navigation system has to perform medical imaging of the anatomy which leads to image analysis. Based on the image generated, the navigation system helps in diagnosis and surgery simulation. The global surgical navigation system market is majorly dominated by the neurosurgery segment owing to the complicated procedures. Orthopedic navigation systems accounted for the second highest share in the global surgical navigation system market, closely followed by ENT navigation system.

Surgical Navigation System Market: Region-wise Outlook

Depending on geographic regions, global Surgical Navigation System market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. Due to the mature healthcare sector in the North American countries, North America held a substantial market share in the global surgical navigation system market and is expected to retain the share over the forecast period. The countries of Japan and Germany are projected to present considerable growth rate in the global surgical navigation system market due to the well-established infrastructure and advanced Information Technology (IT) in healthcare.

Surgical Navigation System Market: Key Players

Some of the key players in the global Surgical Navigation System are GE Healthcare Ltd., Medtronic Inc., Siemens Healthcare Corporation, Stryker Corporation, B.Braun Melsungen AG, Bausch & Lomb Incorporated, CAScination AG and Brainlab AG. The global surgical navigations system manufacturers are involved getting product approvals from Food and Drug Administration (FDA) and other regulatory authorities for market launch of their products. The global surgical navigations system market players are encouraging acquisitions and strategic collaborations to gain competitive advantage, expand into emerging markets and broaden the product portfolio.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-977

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Rest of Western Europe)

Eastern Europe (Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Surgical Navigation System Market: Segmentation

Surgical Navigation System market is classified on the basis disease indication and geography.

Based on disease indication, the global Surgical Navigation System market is segmented into the following:

Neurosurgery Navigation System

Spine Navigation System

ENT Navigation System

Orthopedic Navigation System

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-977

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Magnetic Drive Pump Market Are Expected To Reach A Valuation Of US$ 807.9 Mn Through 2021

The global magnetic drive pump sales are projected to top US$ 807.9 Mn in 2021, as per ESOMAR-certified research and consulting firm Future Market Insights (FMI). With steady growth outlook, the market is poised to register CAGR at nearly 5.3% during 2021-2031. Demand for global magnetic drive pump waned in 2020 due to the outbreak of COVID-19. With the construction industry in recovery mode, the long-term outlook of the market is expected to remain positive.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-10907

Expansion of the construction and mining industries is expected to increase the demand for heavy machinery and equipment, increasing sales in the magnetic drive pump market. As per FMI, increasing application in construction and mining industries is projected to register steady growth across China, India, and Indonesia. As per FMI’s analysis, rapid adoption of technologically advanced equipment and machinery, coupled with increasing application for water treatment activities will spur the sales. Backed by these aforementioned factors, the market is expected to surpass US$ 1.35 Bn by 2031.

In some of the major regions, construction and mining industries are required to adhere to strict legislations to attain certain standards of end-use industry. Government authorities formed to protect the environment such as Pollution Control Agency and Environmental Protection Agency require manufacturers to invest heavily in new technologies to reduce the emission of pollution. However, due to these regulations, manufacturers of industrial pump registered slump in the sales in terms of volume. Moreover, companies operating in the developing economies refrain from investing heavily in advanced technologies due to high initial cost.

Manufacturers are also aiming at strategic collaborations with end users and regional distributors to cater to the rising demand from various industries. Brand consciousness and aggressive marketing make it challenging for new entrants in this market. The leading companies operating in the market are:

Major Key Player:

  • Ebara Corporation
  • Flowserve Corporation
  • Kirloskar Brothers Limited
  • ITT Goulds Pumps Inc.
  • Iwaki Co Ltd.
  • Klaus Union
  • March Manufacturing
  • Ruhrpumpen Inc.
  • Sundyne LLC
  • Xylem Inc.
  • PRECISION ENGINEERING CO.
  • Grosvenor Worldwide Private Limited
  • GCA Energy
  • Magnatex Pumps, Inc.
  • Grundfos
  • TEIKOKU ELECTRIC MFG. CO., LTD.
  • ELEPON E.C.A.P. Corporation
  • NIKKISO EIKO Co., Ltd.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-10907

By Segment:

By Pump Type:

By Flow Rate:

  • Up to 80 m3/hr
  • 81 – 200 m3/hr
  • 201 – 500 m3/hr
  • Above 501 m3/hr

By Casting Material:

  • Stainless Steel
  • Alloy
  • Engineering Plastic
    • PP
    • ETFE
    • PFA
    • CRETFE

By Application:

  • Mining
  • Chemical Manufacturing and Processing
  • Bio-Fuels and Refineries
  • Metal Plating and Finishing
  • Fume Scrubbing
  • Food Processing
  • Water Treatment
  • Surface Treatment
  • Desalination
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-10907

About Industrial Automation Division at Future Market Insights

The Industrial Automation & Equipment division at FMI adopts a novel approach and innovative perspective in analyzing the global machinery and industrial automation market. A range of FMI’s market research reports offer comprehensive coverage of capital, portable, process, construction, industrial, and special purpose machinery used across manufacturing sector. The team also conducts distinctive analysis about installed base, consumables, replacement, and USP-feature application matrix, making us a prominent voice of authority in the industry. We are associates of choice for established as well as budding industry.